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     The major limitation in the application of bioactive molecule is their low permeation across plasma 
membrane. In 1988 it was discovered, that a natural polycationic protein, the trans-acting activator of 
transcription (TAT) of the human immunodeficiency virus (HIV-1), passed very efficiently through cell 
membrane of cultured mammalian cells. TAT became known as the first cell penetrating peptide (CPP). 
CPPs have demonstrated themselves to be capable of delivering biologically active cargo to the cell interior 
and the vehicular capabilities of CPPs have already been harnessed for use as laboratory tools. Attached to a 
CPP, therapeutic cargo could be delivered to an intracellular target, thus overcoming the entry restrictions 
set by the plasma membrane. Since the discovery of TAT, the number of known peptides with cell-
penetrating capabilities has grown and in 2003, the first CPP-based drug reached phase II clinical trials. In 
this review we introduce and discuss the current knowledge of CPPs. 
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INTRODUCTION 
     Cell membrane as a selective permeability 
barrier surrounded the cells. While the 
phospholipid bilayer membrane play important 
role in cell function and survival, but often 
delivering specific material that we need into cells 
is a problem. Reporter molecules and imaging 
agents need to log into live cells for their 
performance, so find a way to bring them into 
cells is essential. In some cases, the chemical 
changes caused increased permeability of cells 
obtained, sometimes chemical changes to transfer 
material into cells cause lose or reduction 
efficiency of our material [1-3].  
Adding synthetic vector is another method to 
increase the penetration into the cells. Among the 
various vectors that are present, cell penetrating 
peptides (CPPs) have become most popular and 
effective techniques for entry into cells. Usually 
CPPs are short cationic sequence peptide that may 
be derived from natural resources or designed 
synthetically [4, 5]. 
The first ability of CPPs was observed in 1988 by 
Frankel and pabo [6]. It was found that (TAT) 
protein of HIV-1 virus could enter into the cell 
and nucleus in cultured cells [6]. Further 
investigations shown for cell penetrating ability of 
TAT did not required whole sequence of TAT and 
small piece of amino acids sequence of the TAT 
is responsible to it and then named TAT peptide. 
The sequence of amino acids 49 to 57 (TAT49-57) 
of the protein in question is causing this effect [7]. 
Using CPP strategy in 1994 when it was 
discovered that the third helix of Antennapedia 
transcription factor called pAntp (43-58) or 
penetratin alone has the ability to cross cell 
membrane [8]. Some of the CPPs maintain its 
ability to cross cell membranes even adding acidic 
or hydrophobic material to them. CPPs ability to 
deliver and pass molecules that cannot enter the 
cells single; they are also called Trojan peptides 
[9]. Researches on CPP peptides have continued 














Source of peptide separation 
 




[9] D. Melanogaster transcription 
factor 
RQIKIWFQNRRMKWKK Penetratin, pAntp 
[7] Viral transcriptional regulator RKKRRQRRR HIV TAT peptide (49-
57) 
[10] HSV-1 Viral Capsid protein DAATATRGRSAASRPTERPRAPARSASR
PRRVD 
VP22 peptide 
[11] Synthetic KLALKLALKALKAALKLA-amide MAP (Model 
amphiphilic peptide) 
[12] Chimeric galanin-mastoparan GWTLNSAGYLLGKINLKALAALAKKIL-
amide 
Transportan 
[13] Synthetic RRRRRRR R7 
[14] Chimeric HIV-1 gp41-SV40 
large T antigen 
GALFLGWLGAAGSTMGAPKKKRKV MPG 
[15] Synthetic KETWWETWWTEWSQPKKKRKV Pep-1 
 
Selection the appropriate CPP peptides, often 
depends on the purpose for which the researcher 
faces. Some commonly used peptides include 
TAT, polyargenin, penetratin and Transportan. 
CPP peptides, particularly in transport of proteins 
into cells so far have been successful [16]. Some 
application of CPPs with emphasis on the effects 
and uses of them in biotechnology are considered 
in this review. 
 
Cellular Uptake of CPPs  
    Although, mechanism of CPPs passage through 
cytoplasmic membrane has been the subject for 
many studies, an integrated mechanism, which 
could explain this translocation, has still remained 
ambiguous. It has been suggested that some of 
characteristics of peptide are effective on its 
translocation and passage including molecular 
length and its static charge at the same time some 
of molecular properties which are accompanied to 
these peptides like size and electric charge may 
have several important impacts on mechanism for 
peptide uptake [17]. First of all, it was posited that 
these peptides could be displaced by direct 
translocation through plasma membrane. This 
model was presented based on biochemical and 
biophysical evidences [18]. Recently, it has been 
shown that endocytosis process may play an 
essential role in entry of cationic (basic) and 
amphipathic CPPs like Antennapedia (Antp), R9, 
and TAT proteins [19]. The study on various 
CPPs through several cellular classes showed that 
the mechanism of arrival depends on 
experimental conditions. In general, it can be 
implied that the mechanism of entry for these 
peptides can be classified into two groups: 1) 
Energy- dependent endocytosis; 2) Direct and 
energy- independent translocation through bi-
laminar phospholipid membrane [20]. In study on 
CCPs endocytosis path, the investigation 
indicated that there is not only one endocytosis 
mechanism to enter these peptides through the 
cell, but macropinocytosis, clathrin-dependent 
endocytosis and Koala- dependent endocytosis 
might contribute to entry of these peptides under 
various conditions as well [21].  
 
Passing of quantum-dots through Blood- Brain- 
Barrier (BBB)  
    Passing through Blood- Brain Barrier (BBB), 
which is made up a series of firm links among 
endothelial cells, is one of the problems for access 
to brain tissues. TAT peptide has been used to 
bring quantum-dots to cerebral tissue of the rat in 
order to penetrate into this barrier in one of these 
studies [22]. In this survey, a micro catheter was 
inserted in rat’s cervical carotid aorta in order to 
reach conjugated TAT peptide to quantum-dot. 
TAT peptide could successfully and quickly reach 
quantum-dots into brain tissue where the rate of 
 




its accumulation in cerebral tissue was to the 
extent that one could observe the florescence of 
rat’s brain tissue by means of UV handheld torch 
with low power as well [22]. The interesting point 
in transferring quantum-dots through Brain- 
Blood- Barrier (BBB) without manipulation in 
animals is referred to this issue that these 
measures can be employed to identify human 
diseases tumors during surgical operation [22].  
 
Application of CPPs to transfer cellular 
biosensors  
    In addition to transferring of scanning agents, 
CPPs may be also utilized in reaching light-
emitting biosensors through the cells. Zn metallic 
element is cofactor for many enzymes, 
transcription factors, protein of immunity system 
and it is considered as the second rare elements in 
human body in terms frequency [23]. Although 
Zn is an important functional element, increase of 
this element is toxic under some conditions like 
disease, ischemic attacks, Alzheimer, and 
epilepsy. Thus, a method can be useful, which 
may measure and track rate of Zn metal and its 
distribution in body or quantity of the existing Zn 
in proteins. In the body, a great amount of Zn 
metallic ion is linked to some agents like proteins, 
glutathione, and histidine so very little amount of 
Zn is found freely and available for measurement 
[24]. For this purpose, fluorescent biosensors may 
be designed and developed to measure 
intracellular Zn surface (ruffling). Human 
carbonic anhydridase enzyme is used as biosensor 
to measure Zn and its link to TAT peptide may 
effectively cause its entry to cell without 
manipulation of cellular membrane [25]. Its signal 
appears quantitatively and it has been shown that 
it is also suitable for measuring Zn ionic surface 
up to less than 5-10 picomolars inside the nucleus 
and cellular cytoplasm. This new and sensitive 
biosensor may be employed to study on Zn ionic 
surface inside the cells as well as surveying Zn 
role in cellular biology [26, 27].  
 
Transferring Peptide Nucleic Acids (PNAs)  
    Peptide Nucleic Acids (PNAs) are synthetic 
polymers, which are synthesized like DNA or 
RNA but they differ from those molecules in that 
they have peptide structure instead of glucose 
structure. During recent years, PNA oligomers 
have been adapted in process of molecular 
biology, diagnostic tests, and anti-sense 
therapeutic methods [28]. Transferring these 
compounds into the cells has been the major 
problem for their application because they lack 
charge. To improve entry inside the cells, some 
agents like receptor of certain ligand and or 
Nuclear Localization Sequence (NLS) were added 
to them [29]. In an investigation that has been 
conducted by Samir Al-Andalusia et al, they 
observed that application of Cell-Penetrating 
Peptide (M918) is effectively responsive to reach 
PNA inside the cell and it resulted in better 
outcomes compared to other techniques for entry 
into the cell [30].  
 
CPPs for delivery of siRNA inside the cell  
    CPPs are used to transfer Small Interfering 
RNA (siRNA) inside the cells to regulate gene 
expression as well. The existing reports indicate 
that application of TAT peptides for transferring 
siRNA inside the cell was very effective and 
caused suppression of gene [31].  
The recent studies have introduced a new CPP 
under title of Peptide for Ocular Delivery (POD) 
that can reach small and big molecules into the 
cells in ocular tissue [32]. POD peptide 
successfully enters siRNAs into human retinal 
stem (embryonic) cells and gene suppression has 
been seen more than 50% of cases. Local use of 
conjugated POD with color in retina of rats has 
also caused their ocular tissue to absorb 
conjugated paint [33]. In the future studies, this 
subject will be explored that if POD peptides can 
transfer medications into ocular cells (without 
side-effects) or not.  
 
Local transfer of medications by CPPs  
    One of the applied aspects of connected 
molecules to CPP peptides, which can be used in 
clinical condition as well, is to used them directly 
on target cells and or at least adjacent to them. For 
instance, in one of the conducted studies, one can 
refer to entering cyclosporine A that is linked to a 
homopolymer from arginine, inside the cell [13]. 
In this study, passing through stratum corneum 
 




and spreading inside epidermis have been 
observed. In 2003, this compound has entered to 
the second phase of clinical test of psoriasis 
disease under trade name of PsorBan®.  
The other example is to intra-coronary injection 
of a compound from C-kinase protein inhibitor (δ) 
together with TAT peptide that has been well-
known under title of KAI-9803 (a delta protein 
kinase C inhibitor) and it will be administered to 
treat several myocardial infarctions. Intra-
coronary infusion of KAI-9803 has entered into 
phase-I of clinical studies on March 2007 [34]. 
Several applications for these peptides can be 
seen in Fig. 1. 
 
Figure 1. Different applications of membrane-penetrating peptides. 
 
CONCLUSION  
    Cell-Penetrating Peptides (CPPs) have shown 
that they could be useful in transferring a wide 
range of bio-molecules into several cellular 
classes in vitro as well as in situ for living 
organisms. Many studies are in-process to 
develop their application as well as specialization 
of these peptides for the tissues and as it 
mentioned before, they could be efficiently useful 
in medical biotechnology.  
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